Pricing Log in Create free account

Adagene Inc. Sponsored ADR (ADAG) vs Coherus Oncology, Inc. (CHRS)

Adagene Inc. Sponsored ADR and Coherus Oncology, Inc. are both Biotechnology companies. Adagene Inc. Sponsored ADR and Coherus Oncology, Inc. are of similar size ($165.3M and $161.1M). Across the 11 metrics below, Adagene Inc. Sponsored ADR leads on 8 and Coherus Oncology, Inc. on 3.

Valuation

Metric ADAG CHRS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.04 9.71
P/B n/m 2.54 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 5.14 9.21
Earnings yield (17.68%) (103.00%) (33.15%)
Free cash flow yield 0.00% (120.77%) (25.50%)

Profitability

Metric ADAG CHRS Biotechnology median
Gross margin — 68.94% 65.16%
Operating margin — (311.56%) 0.00%
Net margin — (259.41%) 0.00%
Free cash flow margin 0.00% (365.22%) 0.00%
Return on equity 0.00% (146.27%) (56.36%)
Return on assets 0.00% (41.90%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAG CHRS Biotechnology median
Revenue growth (TTM) — 61.00% 6.02%
EPS growth (last fiscal year) 49.15% 472.00% 30.26%
Revenue growth, 5-year CAGR 61.38% (38.41%) 9.41%
Net income growth, 5-year CAGR 0.00% 4.91% 0.00%

Health

Metric ADAG CHRS Biotechnology median
Debt to equity 0.01 0.61 0.00
Current ratio 5.02 1.77 4.72
Net debt to EBITDA 3.46 0.76 0.96

Dividend

Metric ADAG CHRS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADAG CHRS Biotechnology median
Market cap 161.14m 165.32m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack